Table 2.
Clinical, laboratory, and imaging characteristics in SARS-CoV-2 patients with and without pericardial effusion.
| Clinical, Laboratory, and Imaging Characteristics | Group A (Median, Q1, Q3) |
Group B (Median, Q1, Q3) |
p-Value | ExpB [CI] |
|---|---|---|---|---|
| Consolidation (% from total lung volume) |
1.7 [1.1; 4.9] | 2.1 [1.1; 3.4] | 0.878 | |
| Mixt lesions (% from total lung volume) |
5.1 [2.5; 9.1] | 4.9 [2.9; 8.1] | 0.263 | |
| Interstitial lesions (% from total lung volume) |
45.1 [36.1; 50.4] | 40.3 [31.9; 52.6] | 0.159 | |
| Normal pulmonary densities (% from total lung volume) |
48.4 [30.3; 56.8] | 52.7 [34.3; 64] | 0.165 | |
| Total pulmonary lesions (% from total lung volume) |
51.6 [43.2; 69.7] | 47.3 [35.9; 65.6] | 0.165 | |
| Heart rate (beats/min) | 80 [67; 89] | 79 [65; 88] | 0.674 | |
| Systolic blood pressure (mmHg) | 130 [108; 140] | 125 [111; 137.5] | 0.635 | |
| Diastolic blood pressure (mmHg) | 75 [68; 83] | 75 [66.5; 82] | 0.607 | |
| Respiratory rate (breaths/minute) | 27 [16; 34] | 24 [20; 30] | 0.03 | 1.078 [1.006; 1.156] |
| Saturation (O2) | 95 [93; 97] | 95 [94; 97] | 0.764 | |
| Median oxygen flow (L/min) | 14 [10; 16] | 14 [10; 24] | 0.912 | |
| FiO2 (%) | 60 [50; 60] | 60 [50; 60] | 0.819 | |
| Arterial O2 pressure (PaO2) | 86 [69; 99] | 81.5 [69.5; 104] | 0.776 | |
| PaO2/FiO2 ratio | 150 [116.6; 210] | 148 [110.8; 216.7] | 0.692 | |
| PCO2 (mmHg) | 38 [34.9; 39] | 36.5 [34; 40] | 0.858 | |
| pH | 7.43 [7.39; 7.45] | 7.45 [7.42; 7.47] | 0.124 | |
| WBC (×103/µL) | 8.8 [6.8; 13] | 8.3 [6.5; 11.1] | 0.262 | |
| Neutrophils (×103/µL) | 6.5 [4.8; 11.2] | 6.4 [4.8; 8.9] | 0.635 | |
| Lymphocytes (×102/µL) | 8 [4; 11] | 8 [6; 11] | 0.771 | |
| Neu/Ly ratio | 9.6 [5.3; 14.3] | 7.5 [4.5; 14] | 0.572 | |
| Platelets (×103/µL) | 281 [211; 345] | 215 [166.5; 294] | 0.05 | 1.003 [1; 1.007] |
| Hemoglobin (g/dL) | 13.5 [12.3; 14] | 13.8 [12.6; 14.5] | 0.202 | |
| CRP (mg/L) | 97 [40; 162] | 56 [17.7; 93.4] | 0.112 | |
| Serum ferritin (ng/mL) | 1331.7 [370.2; 1650] | 827.8 [325.1; 1635.6] | 0.377 | |
| IL6 (pg/mL) | 13.6 [3.7; 55.4] | 16 [2.7; 102] | 0.394 | |
| PAI-1 (ng/mL) | 500.5 [321; 708.7] | 479 [284.7; 738.1] | 0.993 | |
| BNP (ng/L) | 170 [16.5; 1149.5] | 92.5 [22.7; 372.2] | 0.143 | |
| TnI (ng/mL) | 0.03 [0.03; 0.05] | 0.3 [0.3; 0.3] | 0.275 | |
| Myoglobin (ng/mL) | 266 [135.5; 328.7] | 108.5 [84.7; 168.9] | 0.001 | 1.008 [1.003; 1.013] |
| D-dimers (ng/mL) | 285 [190; 680] | 249 [161; 463] | 0.140 | |
| PT (sec) | 13.1 [12; 14.1] | 12.8 [11.9; 13.5] | 0.786 | |
| CK (U/L) | 210 [48; 456] | 62 [34; 127] | 0.001 | 1.003 [1.001; 1.006] |
| CK-MB (U/L) | 13 [9; 28] | 10 [5; 14] | 0.05 | 1.036 [0.997; 1.076] |
| LDH (U/L) | 460 [346; 670] | 354.5 [284.2; 498.7] | 0.009 | 1.003 [1.001; 1.006] |
| ALT (U/L) | 42 [26; 87] | 52.5 [30; 101.7] | 0.292 | |
| AST (U/L) | 52 [38; 82] | 50 [34; 77.5] | 0.347 | |
| Serum creatinine (mg/dL) | 1.1 [0.7; 1.2] | 0.9 [0.7; 1.1] | 0.197 | |
| Serum albumin (g/L) | 3.6 [3.2; 4] | 3.5 [3.3; 49] | 0.414 |